We are live on ! Find out more
TARO

Taro Pharmaceutical Industries Ltd.
TARO

Delisted

TARO was delisted on the 21st of June, 2024.

Back to rankings

105 hedge funds and large institutions have $351M invested in Taro Pharmaceutical Industries Ltd. in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 38 increasing their positions, 29 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 38 | Existing positions reduced: 29

6% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 18

1% more funds holding

Funds holding: 104 → 105 (+1)

21% less capital invested

Capital invested by funds: $444M → $351M (-$93.6M)

Holders
105
Holders Change
+1
Holders Change %
+0.96%
% of All Funds
2.28%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
19
Increased
38
Reduced
29
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$12.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.3M
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$3.9M
4
OAC
OMERS Administration Corp
Ontario, Canada
+$2.82M
5
Morgan Stanley
Morgan Stanley
New York
+$2.45M

Top Sellers

1
AL
AJO LP
Pennsylvania
-$16.6M
2
FCH
Freestone Capital Holdings
Washington
-$10.3M
3
First Manhattan
First Manhattan
New York
-$3.81M
4
Invesco
Invesco
Georgia
-$3.52M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$2.63M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAC
26
OMERS Administration Corp
Ontario, Canada
$2.65M +$2.82M +28,500 +1,357%
HSBC Holdings
27
HSBC Holdings
United Kingdom
$2.58M +$635K +6,424 +27%
AIIMS
28
Analyst IMS Investment Management Services
Israel
$2.43M – – –
SEI Investments
29
SEI Investments
Pennsylvania
$2.36M +$366K +3,697 +15%
Millennium Management
30
Millennium Management
New York
$2.33M +$1.69M +17,087 +168%
Caisse de Depot et Placement du Quebec (CDPQ)
31
Caisse de Depot et Placement du Quebec (CDPQ)
Quebec, Canada
$2.1M +$89K +900 +4%
OAM
32
Oxford Asset Management
United Kingdom
$2.07M +$389K +3,928 +19%
Canada Pension Plan Investment Board
33
Canada Pension Plan Investment Board
Ontario, Canada
$2.03M – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$1.93M +$1.11M +11,197 +98%
AG
35
Aperio Group
California
$1.53M -$9.79K -99 -0.5%
Geode Capital Management
36
Geode Capital Management
Massachusetts
$1.34M +$454K +4,586 +41%
MC
37
Menta Capital
California
$1.31M +$835K +8,440 +123%
Ameriprise
38
Ameriprise
Minnesota
$1.29M +$193K +1,950 +15%
US Bancorp
39
US Bancorp
Minnesota
$1.15M +$437K +4,421 +49%
Goldman Sachs
40
Goldman Sachs
New York
$1.13M -$557K -5,627 -30%
DekaBank Deutsche Girozentrale
41
DekaBank Deutsche Girozentrale
Germany
$1.08M +$1.23M +12,465 New
UBS Group
42
UBS Group
Switzerland
$1.08M +$1.07M +10,794 +602%
AG
43
Algert Global
California
$930K +$674K +6,817 +167%
EF
44
Empirical Finance
Pennsylvania
$817K +$4.95K +50 +0.5%
SFM
45
Systematic Financial Management
New Jersey
$738K -$376K -3,800 -31%
QCM
46
Quantinno Capital Management
New York
$705K +$816K +8,250 New
Marshall Wace
47
Marshall Wace
United Kingdom
$685K +$793K +8,014 New
Capital Fund Management (CFM)
48
Capital Fund Management (CFM)
France
$598K +$692K +7,000 New
SFI
49
Susquehanna Fundamental Investments
Pennsylvania
$590K +$385K +3,895 +129%
EGA
50
Eagle Global Advisors
Texas
$555K – – –
1
2
3 4 5

TARO Hedge Fund Activity: Q2 2019 in Review

105 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Taro Pharmaceutical Industries Ltd. (TARO) for Q2 2019, worth a combined $351M — down 21% from $444M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new TARO positions and 18 closed out — a net gain of 1 holder — while 38 added to existing stakes and 29 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $12.5M. The largest seller was AJO LP, cutting an estimated $16.6M.

  • 105 institutional investors held Taro Pharmaceutical Industries Ltd. (TARO) as of Q2 2019, up from 104 in Q1 2019.
  • Funds reported $351M of Taro Pharmaceutical Industries Ltd. stock for Q2 2019, down 21% quarter-over-quarter.
  • 19 funds opened new Taro Pharmaceutical Industries Ltd. positions in Q2 2019 and 18 closed out, a net change of +1 holder.
  • The largest Taro Pharmaceutical Industries Ltd. buyer in Q2 2019 was Renaissance Technologies, an estimated $12.5M added.
  • The largest Taro Pharmaceutical Industries Ltd. seller in Q2 2019 was AJO LP, an estimated $16.6M sold.

Based on aggregated 13F filings for Q2 2019.